<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03626519</url>
  </required_header>
  <id_info>
    <org_study_id>2018-A00585-50</org_study_id>
    <nct_id>NCT03626519</nct_id>
  </id_info>
  <brief_title>Effects of Menthol on Dyspnoea in COPD Patients</brief_title>
  <acronym>MEDiC</acronym>
  <official_title>Effects of Menthol on Dyspnoea Induced by Exercise in COPD Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Groupe Hospitalier du Havre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Groupe Hospitalier du Havre</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Chronic obstructive pulmonary disease (COPD) is characterised by non-reversible bronchial
      obstruction associated with systemic disorders and comorbid factors. Dyspnoea is a common
      symptom among patients with Chronic Obstructive pulmonary Disease (COPD). Dyspnea is the
      primary symptom limiting exercise and daily activities in these patients. It has been
      reported that breathing cold air could decrease dyspnoea induced by exercise and could
      improve exercise performance. The aim of this study is to carry out the effect of cooling
      sensation induced by menthol chewing-gum on dyspnoea and exercise performance among patients
      with COPD.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 23, 2019</start_date>
  <completion_date type="Anticipated">July 2021</completion_date>
  <primary_completion_date type="Anticipated">July 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Dyspnea after each tests</measure>
    <time_frame>The outcome will be measured before and at the end of the test, the two six-minute walk test will perform the same day, separate from 30 minutes minimum for a total time frame of 1 day.</time_frame>
    <description>Change in dyspnea using Modified Borg Scale (0 - 10 points) 0=no dyspnea ; 10 = maximal effort</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in respiratory rate</measure>
    <time_frame>Data will be continuously collected during every tests. The two six-minute walk test will perform the same day, separate from 30 minutes minimum for a total time frame of 1 day.</time_frame>
    <description>Change in respiratory rate (cycles per minute) will be measured breath-by-breath using a Respiratory Inductive Plethysmography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in inspiratory capacity</measure>
    <time_frame>The outcome will be measured before and at the end of the test, the two six-minute walk test will perform the same day, separate from 30 minutes minimum for a total time frame of 1 day.</time_frame>
    <description>Change in inspiratory capacity (Liters) will be measured using a portable spirometer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Cardiac Frequency</measure>
    <time_frame>Data will be continuously collected during every tests. The two six-minute walk test will perform the same day, separate from 30 minutes minimum for a total time frame of 1 day.</time_frame>
    <description>Change in Cardiac Frequence (bpm) using a pulse oximetry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Oxygen Saturation</measure>
    <time_frame>Data will be continuously collected during every tests. The two six-minute walk test will perform the same day, separate from 30 minutes minimum for a total time frame of 1 day.</time_frame>
    <description>Change in Oxygen Saturation (%) using a pulse oximetry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in tidal volume</measure>
    <time_frame>The outcome will be measured before and at the end of the test, the two six-minute walk test will perform the same day, separate from 30 minutes minimum for a total time frame of 1 day.</time_frame>
    <description>Change in tidal volume (Liters) will be measured breath-by-breath using a portable spirometer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in 6-min walk distance</measure>
    <time_frame>The outcome will be measured at the end of each tests. The two six-minute walk test will perform the same day, separate from 30 minutes minimum for a total time frame of 1 day.</time_frame>
    <description>Change in 6-min walk distance (meters).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">63</enrollment>
  <condition>Copd</condition>
  <condition>Dyspnea</condition>
  <condition>Lung Diseases</condition>
  <arm_group>
    <arm_group_label>Test with Menthol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will chew a menthol flavored chewing gum 5 minutes before perform one Six-minute Walk Test</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Test with placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients will chew a strawberry flavored chewing gum 5 minutes before perform one Six-minute Walk Test</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Test with Menthol</intervention_name>
    <description>patients will perform a Six-minute walk test according to American Thoracic Society guidelines</description>
    <arm_group_label>Test with Menthol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Test with placebo</intervention_name>
    <description>patients will perform a Six-minute walk test according to American Thoracic Society guidelines</description>
    <arm_group_label>Test with placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  a diagnosis of COPD

          -  Dyspnea in daily living (2-4 on the modified medical research council dyspnea scale)

          -  Clinically stable

        Exclusion Criteria:

          -  exercise contraindication Any musculoskeletal problems, cardiovascular or neurological
             comorbidities that limits exercise.

          -  exacerbation during the study

          -  Inability to chew or patients with swallowing disorders
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Guillaume Prieur</last_name>
    <role>Principal Investigator</role>
    <affiliation>Groupe Hospitalier du Havre</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marc Beaumont</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier des Pays de Morlaix</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Guillaume Prieur</last_name>
    <phone>0617916098</phone>
    <email>gprieur.kine@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Centre hospitalier des Pays de Morlaix</name>
      <address>
        <city>Morlaix</city>
        <state>Bretagne</state>
        <zip>29672</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Marc Beaumont</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Groupe Hospitalier du Havre</name>
      <address>
        <city>Le Havre</city>
        <state>Normandie</state>
        <zip>76290</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Guillaume Prieur</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>August 8, 2018</study_first_submitted>
  <study_first_submitted_qc>August 8, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 13, 2018</study_first_posted>
  <last_update_submitted>January 29, 2020</last_update_submitted>
  <last_update_submitted_qc>January 29, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 31, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>COPD</keyword>
  <keyword>Menthol</keyword>
  <keyword>Exercise</keyword>
  <keyword>Dyspnea</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Dyspnea</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Menthol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Data type : deidentified participtant data</ipd_description>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>after publication</ipd_time_frame>
    <ipd_access_criteria>the request shall be sent to Guillaume Prieur (gprieur.kine@gmail.com)</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

